Showing results (31-40 of 103) with videos related to
Sort By:
Pageof 11
Oncology Letters|August 8, 2017
Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancerKa-Rham Kim, Jung-Hwan Yoon, Hyun-Jeong Shim, et al.Cancer Chemotherapy and Pharmacology|February 6, 2016
A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancerHyun-Jeong Shim, Ka-Rham Kim, Jun-Eul Hwang, et al.Frontiers in Oncology|October 26, 2023
Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysisHyeon-Jong Kim, Seung Hyuk Lee, Hyun Jeong Shim, et al.Palliative & Supportive Care|April 18, 2015
Influence of caregiver personality on the burden of family caregivers of terminally ill cancer patientsHa-Hyun Kim, Seon-Young Kim, Jae-Min Kim, et al.Cancer Research and Treatment|November 19, 2016
FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal TransitionSang Hee Cho, Chang Soo Hong, Hee Nam Kim, et al.Investigative and Clinical Urology|March 4, 2022
Tumor enucleation for the treatment of T1 renal tumors: A systematic review and meta-analysisHyun Chul Chung, Tae Wook Kang, Joon Young Lee, et al.Scientific Reports|June 14, 2020
Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 GastrectomyHyun-Jeong Shim, Hyeon-Jong Kim, Seung Hyuk Lee, et al.Biomed Research International|October 1, 2015
A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and VomitingKa-Rham Kim, Gaeun Kang, Myung-Seo Ki, et al.Journal of Cancer Research and Clinical Oncology|July 6, 2019
Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancerJun Eul Hwang, Hyeonjong Kim, Hyun-Jeong Shim, et al.Cell Death Discovery|April 11, 2023
Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α-TAK1-MMP9 axisEun-Gene Sun, Veena Vijayan, Mi-Ra Park, et al.Pageof 11